Novel inhibitors of botulinus neurotoxin "A" based on variations of the SNARE motif.
Hayden
J
J
Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada.
Pires
J
J
Hamilton
M
M
Moore
G
G
D000595:Amino Acid Sequence; D019274:Botulinum Toxins, Type A / Q000037:antagonists & inhibitors* / Q000633:toxicity; D002851:Chromatography, High Pressure Liquid; D008565:Membrane Proteins / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D008969:Molecular Sequence Data; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000494:pharmacology; D019151:Peptide Library; D010455:Peptides / Q000138:chemical synthesis / Q000494:pharmacology; D011487:Protein Conformation; D050600:SNARE Proteins; D050825:Synaptosomal-Associated Protein 25; D033921:Vesicular Transport Proteins
D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D019151:Peptide Library; D010455:Peptides; D050600:SNARE Proteins; D050825:Synaptosomal-Associated Protein 25; D033921:Vesicular Transport Proteins; D019274:Botulinum Toxins, Type A